Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-17 Purchase |
2023-03-20 5:35 pm |
IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer |
25,000 | $2.3207 | $58,018 | 25,000 (Direct) |
View |
| 2021-11-09 Purchase |
2021-11-12 4:16 pm |
IO Biotech Inc. | IOBT | HBM Healthcare Investments (Cayman) Ltd. 10% Owner |
325,000 | $14 | $4,550,000 | 2,690,545 (Direct) |
View |
| 2021-11-09 Purchase |
2021-11-12 4:16 pm |
IO Biotech Inc. | IOBT | Malier Vanessa Director |
325,000 | $14 | $4,550,000 | 430,477 (Indirect) |
View |
| 2021-11-09 Purchase |
2021-11-12 4:16 pm |
IO Biotech Inc. | IOBT | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner |
650,000 | $14 | $9,100,000 | 3,015,545 (Direct) |
View |
| 2021-11-09 Purchase |
2021-11-12 4:16 pm |
IO Biotech Inc. | IOBT | Andersson Claus A. Director |
75,000 | $14 | $1,050,000 | 1,791,490 (Indirect) |
View |
| 2021-11-09 Purchase |
2021-11-12 4:15 pm |
IO Biotech Inc. | IOBT | Lundbeckfond Invest A/S 10% Owner |
2,142,857 | $14 | $29,999,998 | 6,049,452 (Direct) |
View |
| 2021-11-09 Purchase |
2021-11-12 4:15 pm |
IO Biotech Inc. | IOBT | Nielsen Jack Director |
650,000 | $14 | $9,100,000 | 3,015,545 (Indirect) |
View |
| 2021-11-09 Purchase |
2021-11-10 7:04 pm |
IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner |
325,000 | $14 | $4,550,000 | 3,277,932 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-08 Option Award |
2023-06-13 7:54 pm |
N/A 2033-06-08 |
IO Biotech Inc. | IOBT | Hirth Peter Director |
41,533 | $0 | 41,533 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-13 7:54 pm |
N/A 2033-06-08 |
IO Biotech Inc. | IOBT | Glaub Kathleen Sereda Director |
41,533 | $0 | 41,533 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-13 7:54 pm |
N/A 2033-06-08 |
IO Biotech Inc. | IOBT | Elling Christian E Director |
41,533 | $0 | 41,533 (Direct) |
View |
| 2023-03-20 Option Award |
2023-03-22 4:40 pm |
N/A 2033-03-20 |
IO Biotech Inc. | IOBT | Al-Hajj Muhammad Chief Scientific Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2023-03-20 Option Award |
2023-03-22 4:34 pm |
N/A 2033-03-20 |
IO Biotech Inc. | IOBT | Zocca Mai-Britt Chief Executive Officer |
500,000 | $0 | 500,000 (Direct) |
View |
| 2023-03-20 Option Award |
2023-03-22 4:26 pm |
N/A 2033-03-20 |
IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-03-20 Option Award |
2023-03-22 4:21 pm |
N/A 2033-03-20 |
IO Biotech Inc. | IOBT | Burkavage Brian Chief Accounting Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-03-20 Option Award |
2023-03-22 4:13 pm |
N/A 2033-03-20 |
IO Biotech Inc. | IOBT | Ehrnrooth Eva Chief Medical Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-13 4:49 pm |
N/A 2033-01-12 |
IO Biotech Inc. | IOBT | Smith Devin Whittemore General Counsel |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-10-17 Option Award |
2022-10-19 4:54 pm |
N/A 2032-10-17 |
IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer |
288,152 | $0 | 288,152 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 6:25 pm |
N/A 2032-05-31 |
IO Biotech Inc. | IOBT | Burkavage Brian Chief Accounting Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 7:42 pm |
N/A 2032-05-26 |
IO Biotech Inc. | IOBT | Hirth Peter Director |
23,885 | $0 | 23,885 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 7:40 pm |
N/A 2032-05-26 |
IO Biotech Inc. | IOBT | Smith David V Director |
23,885 | $0 | 23,885 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 7:39 pm |
N/A 2032-05-26 |
IO Biotech Inc. | IOBT | Glaub Kathleen Sereda Director |
23,885 | $0 | 23,885 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 7:36 pm |
N/A 2032-05-26 |
IO Biotech Inc. | IOBT | Elling Christian E Director |
23,885 | $0 | 23,885 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 7:34 pm |
N/A 2032-05-26 |
IO Biotech Inc. | IOBT | Nielsen Jack Director |
23,885 | $0 | 23,885 (Direct) |
View |
Ownership |
2022-05-13 4:39 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Burkavage Brian Chief Accounting Officer |
0 | $0 | 54,500 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:30 pm |
N/A 2032-03-01 |
IO Biotech Inc. | IOBT | Smith David V Director |
28,019 | $0 | 28,019 (Direct) |
View |
| 2021-11-09 Conversion |
2021-11-12 4:16 pm |
N/A N/A |
IO Biotech Inc. | IOBT | HBM Healthcare Investments (Cayman) Ltd. 10% Owner |
2,553,713 | $0 | 2,690,545 (Direct) |
View |
| 2021-11-09 Conversion |
2021-11-12 4:16 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Malier Vanessa Director |
1,148,711 | $0 | 430,477 (Indirect) |
View |
| 2021-11-09 Conversion |
2021-11-12 4:16 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner |
2,553,713 | $0 | 3,015,545 (Direct) |
View |
| 2021-11-09 Conversion |
2021-11-12 4:16 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Andersson Claus A. Director |
1,892,596 | $0 | 1,791,490 (Indirect) |
View |
| 2021-11-09 Conversion |
2021-11-12 4:15 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Zocca Mai-Britt Chief Executive Officer |
26,580 | $0 | 26,934 (Indirect) |
View |
| 2021-11-09 Conversion |
2021-11-12 4:15 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Lundbeckfond Invest A/S 10% Owner |
4,276,724 | $0 | 6,049,452 (Direct) |
View |
| 2021-11-09 Conversion |
2021-11-12 4:15 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Nielsen Jack Director |
2,553,713 | $0 | 3,015,545 (Indirect) |
View |
| 2021-11-09 Conversion |
2021-11-10 7:04 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner |
3,245,306 | $0 | 3,277,932 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-08 6:39 pm |
N/A 2031-11-04 |
IO Biotech Inc. | IOBT | Glaub Kathleen Sereda Director |
21,295 | $0 | 21,295 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-08 6:37 pm |
N/A 2031-11-04 |
IO Biotech Inc. | IOBT | Vendola Keith A. Chief Financial Officer |
69,469 | $0 | 69,469 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-08 6:35 pm |
N/A 2031-11-04 |
IO Biotech Inc. | IOBT | Hirth Peter Director |
34,731 | $0 | 34,731 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-08 6:33 pm |
N/A 2031-11-04 |
IO Biotech Inc. | IOBT | Zocca Mai-Britt Chief Executive Officer |
414,212 | $0 | 414,212 (Direct) |
View |
Ownership |
2021-11-04 9:36 pm |
N/A N/A |
IO Biotech Inc. | IOBT | HBM Healthcare Investments (Cayman) Ltd. 10% Owner |
0 | $0 | 2,365,545 (Direct) |
View |
Ownership |
2021-11-04 9:33 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Zocca Mai-Britt Chief Executive Officer |
0 | $0 | 630,726 (Direct) |
View |
Ownership |
2021-11-04 9:33 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Al-Hajj Muhammad Chief Scientific Officer |
0 | $0 | 301,897 (Direct) |
View |
Ownership |
2021-11-04 9:33 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner |
0 | $0 | 2,365,545 (Direct) |
View |
Ownership |
2021-11-04 9:33 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Vendola Keith A. Chief Financial Officer |
0 | $0 | 221,389 (Direct) |
View |
Ownership |
2021-11-04 9:33 pm |
N/A N/A |
IO Biotech Inc. | IOBT | Nielsen Jack Director |
0 | $0 | 2,365,545 (Indirect) |
View |